The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Social Media and Medicine: A Winning Combination
Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, discusses the potential of social media to change the landscape of clinical practice.
The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Phase 3 Data Confirm Strong Immune Response With Pfizer-BioNTech LP.8.1 COVID-19 Vaccine for 2025–2026 Season
New data show the LP.8.1-adapted COVID-19 vaccine generates ≥4-fold antibody increases in older and high-risk adults, with no new safety concerns.
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use
This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.
Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds
Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults
A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.
Data Show Many US Adults Lack Awareness About HPV, Vaccine: Daily Dose
Your daily dose of the clinical news you may have missed.
Phase 3 Data Confirm Strong Immune Response With Pfizer-BioNTech LP.8.1 COVID-19 Vaccine for 2025–2026 Season
New data show the LP.8.1-adapted COVID-19 vaccine generates ≥4-fold antibody increases in older and high-risk adults, with no new safety concerns.
Weekly Dose Podcast: Psoriasis Drug Success, Intranasal Insulin Insights, and New Data on Vaccines and GLP-1 Use
This week’s podcast covers psoriasis trial results, intranasal insulin, COVID-19 booster safety, GLP-1 use in diabetes, and RSV vaccine uptake.
Salt Substitute Use Remains Rare Among US Adults With Hypertension, Two-Decade Survey Finds
Analysis presented at AHA Hypertension 2025 showed fewer than 6% of US adults use salt substitutes, despite their potential to improve BP control.
Weekly Dose Podcast: CRC Screening Uptake, GLP-1 Eligibility in Youth, Women’s Heart Health, and Ultraprocessed Food Risks
This week’s podcast episode covers CRC screening, GLP-1 eligibility in youth, women’s heart health, FIT outreach, and ultraprocessed food risks.
High-Dose Influenza Vaccine Reduces Risk of Myocarditis and Pericarditis in Older Adults
A secondary analysis of the DANFLU-2 trial found adults ≥65 receiving a high-dose flu vaccine had a 46% lower risk of myocarditis or pericarditis compared with standard-dose vaccination.
Data Show Many US Adults Lack Awareness About HPV, Vaccine: Daily Dose
Your daily dose of the clinical news you may have missed.